Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Anadolu Hayat Emeklilik Anonim Sirketi (ANHYT.IS)
Istanbul, TR
Anadolu Hayat Emeklilik Anonim Sirketi, a subsidiary of Türkiye Is Bankasi A.S. since its founding in 1990, operates from its headquarters in Istanbul, Turkey. The company specializes in offering a comprehensive suite of individual and group private pension and life insurance solutions across Turkey. Its diverse pension plans include individual, non-sponsored group, employer-sponsored, and income drawdown schemes, alongside auto-enrolment programs. For life insurance, Anadolu Hayat provides various options such as savings and endowment policies, annuity products, and term life coverage. Additionally, the company extends its services to encompass personal and group accident insurance, as well as reinsurance activities. Customers can access these offerings through a multi-channel distribution network comprising a direct sales force, bank branches acting as agencies, an independent agency network, and other alternative distribution methods. The firm adopted its present name in 2003, having previously operated as Anadolu Hayat Sigorta A.S.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.70% | -5.05% | -8.39% | -9.45% | +7.00% | +3.41% | +31.18% | +500.47% | +1,009.17% | +2,007.88% | +16,326.84% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | -1 |
| Buy | 3 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%+28.5% ★ Q1'26: +10.1% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%+39.3% ★ Q1'26: +45.9% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%+2.4% Q1'26: +23.7% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+8.8% Q1'26: +26.5% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%— Q1'26: +135.0% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×0.11× ★ Q1'26: 0.04× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|
| Revenue |
23.27B
est: 12.44B (+87.0%)
|
29.90B
est: 22.89B (+30.6%)
|
| EBITDA |
5.82B
est: 2.44B (+138.1%)
|
2.75B
est: 4.49B (-38.8%)
|
| EBIT |
5.74B
est: 2.38B (+140.8%)
|
2.62B
est: 4.38B (-40.3%)
|
| Net Income |
4.31B
est: 4.59B (-6.2%)
|
5.99B
est: 7.21B (-16.9%)
|
| SGA |
777.80M
est: 401.84M (+93.6%)
|
1.22B
est: 739.07M (+65.0%)
|
| EPS |
10.01
est: 10.67 (-6.2%)
|
13.94
est: 16.77 (-16.9%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | A- | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-15 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 4/5 | 1/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 4/5 | 1/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-04-29 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 4/5 | 1/5 |
| 2026-04-22 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 1/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 1/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 4/5 | 1/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 1/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Sophus Capital Emerging Market Small Cap ETF EMSC | 0.77% | 343.5K | 0.85% |
| 2 | State Street SPDR S&P Emerging Markets Dividend Aristocrats UCITS ETF (Dist) EDVD.L | 0.41% | 710.0K | 0.55% |
| 3 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.02% | 364.9K | 0.58% |
| 4 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.02% | 20.3K | 0.42% |
| 5 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.02% | 7.2K | 0.54% |
| 6 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.01% | 22.9K | 0.33% |
| 7 | WisdomTree Emerging Markets High Dividend Fund DEM | 0.00% | 172.2K | 0.63% |
| 8 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 22.4K | 0.44% |
| 9 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.00% | 4.2K | 0.33% |
| 10 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 17.6K | 0.48% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ahmet Altinsoy | Deputy Chief Executive Officer & Member of Executive Board | — | male |
| Burak Coskun | Head of the Board of Internal Audit | — | male |
| Cavit Ozan Sezer | Accounting Manager, Financial Management & Investor Relations Director | — | male |
| Digdem Makaskesen | Deputy Chief Executive Officer & Member of Executive Board | — | female |
| Ismail Hakki Altay | Deputy Chief Executive Officer & Member of Executive Board | — | male |
| Mehmet Gurpinar | Head of Internal Control & Compliance Officer | — | male |
| Necdet Cem Ozcan | Deputy Chief Executive Officer & Member of the Executive Board | — | male |
| Serkan Ugras Kaygalak | Chief Executive Officer, Member of Executive Board & Director | — | male |
| Tayfun Ceyhun | Deputy Chief Executive Officer & Member of the Executive Board | — | male |
| Zeynep Dolgun | Deputy Chief Executive Officer & Member of Executive Board | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ANHYT.IS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
